QualiMetriX is a third-party contract laboratory specializing in providing analytical services to the pharmaceutical industry. The company is dedicated to supporting pharmaceutical products throughout their entire lifecycle, from development to registration and post-marketing stages. Its services cover a wide range of areas, from routine to highly complex products, with a strong emphasis on meeting regulatory requirements and research challenges. Operating in an environment of Good Laboratory and Manufacturing Practices, QualiMetriX offers a comprehensive suite of services, including analytical development and validation, leachables and extractables testing, filter validation, elemental impurities analysis, stability studies, and batch release services. Headquartered in Greece, QualiMetriX serves the analytics and pharmaceutical industries. While there's no publicly available information about its last investment or its investors, the company's focus on quality control and analytical support for pharmaceutical products positions it as an attractive prospect for potential venture capital investment. With the increasing emphasis on pharmaceutical quality and compliance, QualiMetriX presents an opportunity for investors looking to tap into the growing demand for high-quality analytical laboratory services in the pharmaceutical sector.
There is no investment information
No recent news or press coverage available for QualiMetrix S.A..